跳至主要内容
临床试验/NCT03591913
NCT03591913已完成4 期

Comparison Between Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section : a Randomized Clinical Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
500
试验地点
1
主要终点
mean intraoperative blood loss

研究概览

简要总结

Cesarean section is one of the most common major surgical operations among women. In 2015, the incidence of cesarean section in Woman Health Hospital in Assiut University accounts for 51.3 % of all deliveries

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
Female
接受健康志愿者

入选标准

  • All pregnant women who will undergo elective lower segment cesarean section
  • term ( ≥ 37 weeks)
  • normal fetal heart tracing.

排除标准

  • Placenta previa-Rupture uterus
  • Classical cesarean section
  • Preterm delivery
  • Hypertensive disorders of pregnancy
  • Bleeding tendency
  • Previous history of postpartum hemorrhage
  • Concurrent anticoagulant therapy
  • Concurrent long-term use of steroids
  • Fetal distress
  • Antepartum haemorrhage

研究组 & 干预措施

study group

Experimental

will receive sublingual misoprostol immediately after urinary catheterization and before skin incision

干预措施: Misoprostol (Drug)

control group

Active Comparator

will receive sublingual misoprostol immediately after skin closure

干预措施: Misoprostol (Drug)

结局指标

主要结局

mean intraoperative blood loss

时间窗: 24 hours

Blood loss estimation will commence immediately following the skin incision

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验

Preoperative and Postoperative Sublingual... | 临床试验